Company Filing History:
Years Active: 2024
Title: Innovations of Chih Kuo Kao in Allergy Regulation
Introduction
Chih Kuo Kao is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of immunology, particularly in the development of anti-allergic peptides. His work aims to provide solutions for individuals suffering from allergic reactions.
Latest Patents
Chih Kuo Kao holds 1 patent for his invention titled "Anti-allergic peptide and use thereof for immune regulation and anti-allergy." This invention presents an anti-allergic peptide that effectively inhibits the secretion of cytokines associated with allergic reactions. The peptide is designed to regulate allergic responses and comprises specific amino acid sequences, as detailed in SEQ ID No: 1 through SEQ ID No: 5, or homologous sequences derived from modifications of these sequences.
Career Highlights
Chih Kuo Kao is currently associated with Greenyn Biotechnology Co., Ltd. His role in the company allows him to further his research and development efforts in the field of biotechnology, focusing on innovative solutions for allergy management.
Collaborations
Chih Kuo Kao collaborates with talented individuals such as Pang Kuei Hsu and Yu Cheng Lin. Their combined expertise contributes to the advancement of research in immunology and biotechnology.
Conclusion
Chih Kuo Kao's innovative work in developing anti-allergic peptides showcases his commitment to improving health outcomes for individuals with allergies. His contributions to the field are significant and reflect the potential for future advancements in allergy treatment.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.